SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding the Fairness of the Sale of Vitae Pharmaceutica...
16 September 2016 - 12:43AM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All Persons or Entities who purchased Vitae
Pharmaceuticals, Inc. (“Vitae Pharmaceuticals”) (NASDAQ:
VTAE) stock prior to September 14,
2016.
You are hereby notified that Levi & Korsinsky, LLP
has commenced an investigation into the fairness of the
sale of Vitae Pharmaceuticals to Allergan plc for $21.00 per
share. The transaction has a total approximate value of $639
million. To learn more about the action and your rights, go
to:
http://zlk.9nl.com/vitae-pharmaceuticals-vtae
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut, California, and Washington D.C. The
firm’s attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities lawsuits and have recovered
hundreds of millions of dollars for aggrieved shareholders. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160915005921/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
212-363-7171www.zlk.com
VITAE PHARMACEUTICALS, INC (NASDAQ:VTAE)
Historical Stock Chart
From Jan 2025 to Feb 2025
VITAE PHARMACEUTICALS, INC (NASDAQ:VTAE)
Historical Stock Chart
From Feb 2024 to Feb 2025
Real-Time news about Vitae Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Vitae Pharmaceuticals, Inc. (MM) News Articles